Because then we'd have to question everything we've been taught to believe.We all see what we want to see.... and half of us don't even have our eyes open because we are afraid of what we may see.....
Because then we'd have to question everything we've been taught to believe.We all see what we want to see.... and half of us don't even have our eyes open because we are afraid of what we may see.....
Been a bit, but just want to present the current info about the effectiveness of hydroxychloroquine. This is not meant to be political at all, just want to see if anyone that was previously a proponent of it has changed their mind https://www.cbc.ca/news/world/franc...xychloroquine-as-covid-19-treatment-1.5586220
there are many studies going onthe use of hydroxychloroquine It will be interesting if they have similar results. This study contradicts other studies done. If you read the article there are changes in the protocol that may explain the differences.Hmm
July 02, 2020
DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.
In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.
The study was published today in the International Journal of Infectious Diseases, the peer-reviewed, open-access online publication of the International Society of Infectious Diseases (ISID.org).
“The findings have been highly analyzed and peer-reviewed,” said Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, who co-authored the study with Henry Ford epidemiologist Dr. Samia Arshad. “We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring. Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.”
https://www.henryford.com/news/2020/07/hydro-treatment-study